Beyond the Database: Integration of Network Pharmacology and UHPLC‐QTOF‐MS/MS to Reveal the Neuroprotective Potential of Bai Mi Decoction in Stroke Therapy
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Fangfang Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Neuroprotective Agents, Network Pharmacology, Tandem Mass Spectrometry. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Key Research and Invention Program of Ningxia, National Natural Science Foundation of China, Natural Science Foundation of Ningxia.
Themen: Schlaganfall
Abstract (Originalsprache)
Network pharmacology is instrumental in understanding how TCM works by targeting specific pathways. This study examines different mechanisms using three network pharmacology approaches, focusing on the TCM “Bai Mi Decoction” (BMD). The neuroprotective effects of BMD were evaluated in a middle cerebral artery occlusion–reperfusion (MCAO/R) rat model. The composition of BMD extract (BMDE) and its components in brain (BMDB) were analyzed using UHPLC‐QTOF‐MS/MS, alongside documented constituents from the database (BMDD). A network pharmacological analysis was conducted to explore the similarities and differences in BMD's neuroprotective mechanisms. BMD showed a strong neuroprotective effect in MCAO/R rats, as indicated by lower neurological deficit scores, smaller cerebellar infarct sizes, and improved histopathological changes. Analysis identified 45, 11, and 22 components in BMDE, BMDB, and BMDD, respectively, with 29, 26, and 23 potential therapeutic targets. However, most database‐listed compounds were not found in actual samples. Functional enrichment and pathway network analysis showed that BMDE and BMDB shared the most targets. MAPK1 was the only common target across all groups, targeted by crocetin, the sole shared compound. BMD proved highly effective in MCAO/R rats, with compounds found in BMD extracts or in vivo better reflecting the actual pharmacological mechanisms than database‐derived ones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Ningxia Medical University, Yinchuan, China.
- Ningxia Health Vocational and Technical College, Shizuishan, China.
- School of Laboratory Medicine, Ningxia Medical University, Yinchuan, China.
ORCID-Profile: Xueqin Ma
Förderung
- Key Research and Invention Program of Ningxia
- National Natural Science Foundation of China
- Natural Science Foundation of Ningxia
- Natural Science Foundation of Ningxia Province
Zitieren
APA
Lu, F., Gao, T., He, X., Yang, L., Ma, X., & Ding, S. (2026). Beyond the Database: Integration of Network Pharmacology and UHPLC‐QTOF‐MS/MS to Reveal the Neuroprotective Potential of Bai Mi Decoction in Stroke Therapy. Biomedical Chromatography. https://doi.org/10.1002/bmc.70281
Vancouver
Lu F, Gao T, He X, Yang L, Ma X, Ding S. Beyond the Database: Integration of Network Pharmacology and UHPLC‐QTOF‐MS/MS to Reveal the Neuroprotective Potential of Bai Mi Decoction in Stroke Therapy. Biomedical Chromatography. 2026. doi:10.1002/bmc.70281
BibTeX
@article{Lu2026,
author = {Lu, Fangfang and Gao, Tao and He, Xinmin and Yang, Lingling and Ma, Xueqin and Ding, Shuqin},
title = {Beyond the Database: Integration of Network Pharmacology and UHPLC‐QTOF‐MS/MS to Reveal the Neuroprotective Potential of Bai Mi Decoction in Stroke Therapy},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70281}
}
EUVIMED